Propensity of red blood cells to undergo P2X7 receptor-mediated phosphatidylserine exposure does not alter during in vivo or ex vivo aging

Transfusion

Volumn 55, Issue 8, 2015, Pages 1946-1954

  Sophocleous, Reece A ^a,b   Mullany, Phillip R F ^a,b   Winter, Kelly M ^c   Marks, Denese C ^c   Sluyter, Ronald ^a,b  

^a UNIVERSITY OF WOLLONGONG   (Australia)

^b ILLAWARRA HEALTH AND MEDICAL RESEARCH INSTITUTE   (Australia)

^c AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

3 [[5 (2,3 DICHLOROPHENYL) 1H TETRAZOL 1 YL]METHYL]PYRIDINE; AZ 10606120; ETHIDIUM; LIPOCORTIN 5; MRS 2159; NF 499; PHOSPHATIDYLSERINE; PURINERGIC P2X7 RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; SODIUM CHLORIDE; UNCLASSIFIED DRUG; 3-(5-(2,3-DICHLOROPHENYL)-1H-TETRAZOL-1-YL)METHYLPYRIDINE; 4,4,',4'',4'''-(CARBONYLBIS(IMINO-5,1,3-BENZENETRIYLBIS(CARBONYLIMINO)))TETRAKIS(BENZENE-1,3-DISULFONATE); ADAMANTANE; ADENOSINE TRIPHOSPHATE; AMINOQUINOLINE DERIVATIVE; AZ10606120; AZO COMPOUND; BENZENESULFONIC ACID DERIVATIVE; MEMBRANE LIPID; MRS2159; PURINERGIC P2X RECEPTOR ANTAGONIST; PURINERGIC P2X1 RECEPTOR; PYRIDINE DERIVATIVE; PYRIDOXAL 5 PHOSPHATE; TETRAZOLE DERIVATIVE;

AGING; ARTICLE; AUSTRALIAN; BLOOD BANK; CONTROLLED STUDY; DRUG EFFICACY; ERYTHROCYTE; EX VIVO STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VIVO STUDY; INCUBATION TIME; LYSIS; MALE; OSMOTIC FRAGILITY; PRACTICE GUIDELINE; PROTEIN BINDING; ANALOGS AND DERIVATIVES; BLOOD; BLOOD STORAGE; CELL AGING; DRUG EFFECTS; ERYTHROCYTE MEMBRANE; METABOLISM; PHYSIOLOGY;

ADAMANTANE; ADENOSINE TRIPHOSPHATE; AMINOQUINOLINES; ANNEXIN A5; AZO COMPOUNDS; BENZENESULFONATES; BLOOD PRESERVATION; CELL AGING; ERYTHROCYTE MEMBRANE; HUMANS; MEMBRANE LIPIDS; OSMOTIC FRAGILITY; PHOSPHATIDYLSERINES; PURINERGIC P2X RECEPTOR ANTAGONISTS; PYRIDINES; PYRIDOXAL PHOSPHATE; RECEPTORS, PURINERGIC P2X1; RECEPTORS, PURINERGIC P2X7; TETRAZOLES;

EID: 84938940270     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.13101     Document Type: Article

References (48)

1. Bosman GJ,. Survival of red blood cells after transfusion: processes and consequences. Front Physiol 2013; 4: 376.
2. Stewart A, Urbaniak S, Turner M, et al., The application of a new quantitative assay for the monitoring of integrin-associated protein CD47 on red blood cells during storage and comparison with the expression of CD47 and phosphatidylserine with flow cytometry. Transfusion 2005; 45: 1496-503.
3. Boas FE, Forman L, Beutler E,. Phosphatidylserine exposure and red cell viability in red cell aging and in hemolytic anemia. Proc Natl Acad Sci U S A 1998; 95: 3077-81.
4. Bosman GJ, Werre JM, Willekens FL, et al., Erythrocyte ageing in vivo and in vitro: structural aspects and implications for transfusion. Transfus Med 2008; 18: 335-47.
5. de Back DZ, Kostova EB, van Kraaij M, et al., Of macrophages and red blood cells; a complex love story. Front Physiol 2014; 5: 9.
6. Bosman GJ, Cluitmans JC, Groenen YA, et al., Susceptibility to hyperosmotic stress-induced phosphatidylserine exposure increases during red blood cell storage. Transfusion 2011; 51: 1072-8.
7. Lang KS, Duranton C, Poehlmann H, et al., Cation channels trigger apoptotic death of erythrocytes. Cell Death Differ 2003; 10: 249-56.
8. Sluyter R, Shemon AN, Hughes WE, et al., Canine erythrocytes express the P2X7 receptor: greatly increased function compared with human erythrocytes. Am J Physiol Regul Integr Comp Physiol 2007; 293: R2090-8.
9. 7 receptor activation causes phosphatidylserine exposure in human erythrocytes. Biochem Biophys Res Commun 2007; 355: 169-73.
10. Skals M, Jorgensen NR, Leipziger J, et al., α-hemolysin from Escherichia coli uses endogenous amplification through P2X receptor activation to induce hemolysis. Proc Natl Acad Sci U S A 2009; 106: 4030-5.
11. Wang L, Olivecrona G, Götberg M, et al., ADP acting on P2Y13 receptors is a negative feedback pathway for ATP release from human red blood cells. Circ Res 2005; 96: 189-96.
12. Kaczmarek-Hájek K, Lörinczi E, Hausmann R, et al., Molecular and functional properties of P2X receptors-recent progress and persisting challenges. Purinergic Signal 2012; 8: 375-417.
13. Winter KM, Johnson L, Kwok M, et al., Red blood cell in vitro quality and function is maintained after S-303 pathogen inactivation treatment. Transfusion 2014; 54: 1798-807.
14. Minetti G, Egée S, Mörsdorf D, et al., Red cell investigations: art and artefacts. Blood Rev 2013; 27: 91-101.
15. Farrell AW, Gadeock S, Pupovac A, et al., P2X7 receptor activation induces cell death and CD23 shedding in human RPMI 8226 multiple myeloma cells. Biochim Biophys Acta 2010; 1800: 1173-82.
16. Veale MF, Healey G, Sparrow RL,. Effect of additive solutions on red blood cell (RBC) membrane properties of stored RBCs prepared from whole blood held for 24 hours at room temperature. Transfusion 2011; 51: 25S-33S.
17. Pupovac A, Stokes L, Sluyter R,. CAY10593 inhibits the human P2X7 receptor independently of phospholipase D1 stimulation. Purinergic Signal 2013; 9: 609-19.
18. Bhavsar SK, Eberhard M, Bobbala D, et al., Monensin induced suicidal erythrocyte death. Cell Physiol Biochem 2010; 25: 745-52.
19. 2+-induced erythrocyte 'apoptosis'. Cell Physiol Biochem 2004; 14: 241-8.
20. + loss. Cell Physiol Biochem 2007; 20: 35-44.
21. Gadeock S, Pupovac A, Sluyter V, et al., P2X7 receptor activation mediates organic cation uptake into human myeloid leukaemic KG-1 cells. Purinergic Signal 2012; 8: 669-76.
22. Bartlett R, Stokes L, Sluyter R,. The P2X7 receptor channel: recent developments and the use of P2X7 antagonists in models of disease. Pharmacol Rev 2014; 66: 638-75.
23. Werre JM, Willekens FL, Bosch FH, et al., The red cell revisited-matters of life and death. Cell Mol Biol (Noisy-le-grand) 2004; 50: 139-45.
24. Sluyter R, Shemon AN, Barden JA, et al., Extracellular ATP increases cation fluxes in human erythrocytes by activation of the P2X7 receptor. J Biol Chem 2004; 279: 44749-55.
25. 7 receptor mediates the uptake of organic cations in canine erythrocytes and mononuclear leukocytes: comparison to equivalent human cell types. Purinergic Signal 2009; 5: 385-94.
26. 7 receptor. Br J Pharmacol 2008; 153: 737-50.
27. Nelson DW, Gregg RJ, Kort ME, et al., Structure-activity relationship studies on a series of novel, substituted 1-benzyl-5-phenyltetrazole P2X7 antagonists. J Med Chem 2006; 49: 3659-66.
28. Braun K, Rettinger J, Ganso M, et al., NF449: a subnanomolar potency antagonist at recombinant rat P2X1 receptors. Naunyn Schmiedebergs Arch Pharmacol 2001; 364: 285-90.
29. Brown SG, King BF, Kim YC, et al., Activity of novel adenine nucleotide derivatives as agonists and antagonists at recombinant rat P2X receptors. Drug Dev Res 2000; 49: 253-9.
30. Donnelly-Roberts DL, Namovic MT, Han P, et al., Mammalian P2X7 receptor pharmacology: comparison of recombinant mouse, rat and human P2X7 receptors. Br J Pharmacol 2009; 157: 1203-14.
31. Bianchi BR, Lynch KJ, Touma E, et al., Pharmacological characterization of recombinant human and rat P2X receptor subtypes. Eur J Pharmacol 1999; 376: 127-38.
32. Hejl JL, Skals M, Leipziger J, et al., P2X receptor stimulation amplifies complement-induced haemolysis. Pflugers Arch 2013; 465: 529-41.
33. Munksgaard PS, Vorup-Jensen T, Reinholdt J, et al., Leukotoxin from Aggregatibacter actinomycetemcomitans causes shrinkage and P2X receptor-dependent lysis of human erythrocytes. Cell Microbiol 2012; 14: 1904-20.
34. Skals M, Leipziger J, Praetorius HA,. Haemolysis induced by α-toxin from Staphylococcus aureus requires P2X receptor activation. Pflugers Arch 2011; 462: 669-79.
35. Ghashghaeinia M, Cluitmans JC, Akel A, et al., The impact of erythrocyte age on eryptosis. Br J Haematol 2012; 157: 606-14.
36. 4- receptor-operated ion channel of human lymphocytes: inhibition of ion fluxes by amiloride analogs and by extracellular sodium ions. Arch Biochem Biophys 1992; 292: 411-8.
37. Fuller SJ, Stokes L, Skarratt KK, et al., Genetics of the P2X7 receptor and human disease. Purinergic Signal 2009; 5: 257-62.
38. Sluyter R, Stokes L,. Significance of P2X7 receptor variants to human health and disease. Recent Pat DNA Gene Seq 2011; 5: 41-54.
39. 7 receptor containing the Ala-348 to Thr polymorphism exhibit a gain-of-function effect and enhanced interleukin-1beta secretion. FASEB J 2010; 24: 2916-27.
40. Dinkla S, Peppelman M, Van Der Raadt J, et al., Phosphatidylserine exposure on stored red blood cells as a parameter for donor-dependent variation in product quality. Blood Transfus 2014; 12: 204-9.
41. Jiang H, Zhu AG, Mamczur M, et al., Stimulation of rat erythrocyte P2X7 receptor induces the release of epoxyeicosatrienoic acids. Br J Pharmacol 2007; 151: 1033-40.
42. + channels and muscarinic and purinergic receptors identified in human erythroid progenitor cells and red blood cell ghosts. Proc Natl Acad Sci U S A 2004; 101: 12730-4.
43. Constantinescu P, Wang B, Kovacevic K, et al., P2X7 receptor activation induces cell death and microparticle release in murine erythroleukemia cells. Biochim Biophys Acta 2010; 1798: 1797-804.
44. Wang B, Sluyter R,. P2X7 receptor activation induces reactive oxygen species formation in erythroid cells. Purinergic Signal 2013; 9: 101-12.
45. Daniels G,. Functions of red cell surface proteins. Vox Sang 2007; 93: 331-40.
46. Thomas SL, Bouyer G, Cueff A, et al., Ion channels in human red blood cell membrane: actors or relics? Blood Cells Mol Dis 2011; 46: 261-5.
47. 2+ rise in Plasmodium berghei and Plasmodium yoelii malaria parasites. Malar J 2012; 11: 69.
48. Levano-Garcia J, Dluzewski AR, Markus RP, et al., Purinergic signalling is involved in the malaria parasite Plasmodium falciparum invasion to red blood cells. Purinergic Signal 2010; 6: 365-72.